SEC Form 4 · accession 0001547522-15-000038
COATES INTERNATIONAL LTD · COTE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory G Coates
Officer — Secretary and Pres, Tech. Div. · Director
Period of report
Feb 19, 2015
Accepted (ET)
Feb 20, 2015 · 12:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000948426
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred StockF1,F3,F2 | $0.00 | Feb 19, 2015 | A | 4,266 | A | Feb 19, 2017 | — | Common Stock | 4,266,000 | 58,110 | D |
Explanation of responses
- F1The anti-dilution award to Gregory Coates was determined to be the number of shares of Series B required to maintain his ownership percentage of common stock at 5.31% of the pro forma number of shares of common stock outstanding, assuming all shares of Series B Convertible Preferred Stock are converted to common stock. This was his percentage ownership of common stock at December 31, 2002. The number of such shares issued was based on this program. This anti-dilution program does not apply to exercises of employee stock options and common stock issued pursuant to a secondary public offering of common stock.
- F2There is no expiration date.
- F3Explanation of Responses: 1. The anti-dilution award to Gregory Coates was determined to be the number of shares of Series B required to maintain his ownership percentage of common stock at 5.31% of the pro forma number of shares of common stock outstanding, assuming all shares of Series B Convertible Preferred Stock are converted to common stock. This was his percentage ownership of common stock at December 31, 2002. The number of such shares issued was based on this program. This anti-dilution program does not apply to exercises of employee stock options and common stock issued pursuant to a secondary public offering of common stock. 2. There is no expiration date. 3. Each share of Series B entitles the holder to 1,000 votes at any meeting where corporate matters are brought before the shareholders for a vote. The Series B is restricted, unregistered stock which is not convertible until the 2nd annual anniversary after the date of issue, after which each share is freely convertible.